Back to Archived Journals » Oncolytic Virotherapy » Volume 8 » default
Oncolytic Virotherapy ceased publishing in January 2023. All articles that have been published in Oncolytic Virotherapy will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Oncolytic Virotherapy
ISSN: 2253-1572
- View all (70)
- Volume 10, 2021 (1)
- Volume 9, 2020 (2)
- Volume 8, 2019 (6)
- Volume 7, 2018 (11)
- Volume 6, 2017 (6)
- Volume 5, 2016 (10)
- Volume 4, 2015 (20)
- Volume 3, 2014 (8)
- Volume 2, 2013 (5)
- Volume 1, 2012 (1)
Archive: Volume 8, 2019
Impact of Induced Syncytia Formation on the Oncolytic Potential of Myxoma Virus
Burton C, Bartee MY, Bartee E
Oncolytic Virotherapy 2019, 8:57-69
Published Date: 9 December 2019
Virus–Receptor Interactions: Structural Insights For Oncolytic Virus Development
Jayawardena N, Burga LN, Poirier JT, Bostina M
Oncolytic Virotherapy 2019, 8:39-56
Published Date: 29 October 2019
Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma
Kiyokawa J, Wakimoto H
Oncolytic Virotherapy 2019, 8:27-37
Published Date: 24 October 2019
Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypes
Zainutdinov SS, Kochneva GV, Netesov SV, Chumakov PM, Matveeva OV
Oncolytic Virotherapy 2019, 8:9-26
Published Date: 12 July 2019
A cautionary note on the selectivity of oncolytic poxviruses
Tang B, Guo ZS, Bartlett DL, Liu J, McFadden G, Shisler JL, Roy EJ
Oncolytic Virotherapy 2019, 8:3-8
Published Date: 11 February 2019
Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma [Corrigendum]
Babiker HM, Riaz IR, Husnain M, Borad MJ
Oncolytic Virotherapy 2019, 8:1-2
Published Date: 4 January 2019